✦ LIBER ✦

5.10 Combination of Bendamustine and Ofatumumab (Bendofa) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Preliminary Report

✍ Scribed by Agostino Cortelezzi; Anna Marina Liberati; Giuseppe Gritti; Antonio Cuneo; Gianluigi Reda; Luca Laurenti; Fortunato Morabito; Francesca R. Mauro; Alfonso Piciocchi; Marco Vignetti; Robin Foà

Book ID: 119218956
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 104 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.9 Bendamustine and Alemtuzumab Combina

5.9 Bendamustine and Alemtuzumab Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia: Interim Report of the Italian Trial

✍ A. Tedeschi; M. Coscia; D. Rossi; F. Ricci; G. D'arena; E. Orlandi; V. Belsito P 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 89 KB

Combination therapy with ofatumumab and

Combination therapy with ofatumumab and bendamustine in xenograft model of chronic lymphocytic leukaemia

✍ Zdenka Haskova; Margaret N. Whitacre; Kimberly A. Dede; Judithann M. Lee; Stephe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

5.56 Ofatumumab in Combination with High

5.56 Ofatumumab in Combination with High-Dose Methylprednisolone as a Salvage Treatment for Heavily Pretreated or Refractory Patients with Chronic Lymphocytic Leukemia

✍ Juan S. Barajas-Gamboa; Julio A. Diaz-Perez; Lina M. Ariza-Serrano; John M. Hort 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 68 KB

Bendamustine in Combination With Rituxim

Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Bottcher, S.; Bahlo, J.; Schubert, J.; Pflug 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 156 KB

5.23 Phase 2 Study of Navitoclax (ABT-26

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results

✍ John F. Seymour; Andrew W. Roberts; Dennis A. Carney; Martin J.S. Dyer; Thomas J 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 71 KB